Table 4 HPV-specific risks for HSIL and higher lesions
From: HPV-specific risk assessment of cervical cytological abnormalities
HPV genotype | LSIL- | HSIL+ | P | OR (for HSIL+) | 95%CI |
|---|---|---|---|---|---|
HPV-16 | 138 (6.3%) | 9 (31.0%) | < 0.001 | 6.708 | 3.00–15.01 |
HPV-31 | 23 (1.0%) | 2 (6.9%) | 0.011 | 6.995 | 1.57–31.16 |
HPV-33 | 40 (1.8%) | 4 (13.8%) | < 0.001 | 8.62 | 2.87–25.92 |
HPV-52 | 164 (7.5%) | 1 (3.4%) | 0.424 | 0.442 | 0.06–3.27 |
HPV-58 | 99 (4.5%) | 6 (20.7%) | < 0.001 | 5.523 | 2.20–13.87 |
HPV-6 | 19 (0.9%) | 1 (3.4%) | 0.177 | 4.09 | 0.53–31.62 |
multiple HPV infection | 170 (7.7%) | 2 (6.9%) | 0.865 | 0.882 | 0.208–3.742 |